Validity and Reliability of 6-minute Pegboard and Ring Test in Patients With Interstitial Lung Disease
Launched by GAZI UNIVERSITY · Apr 22, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the 6-minute pegboard and ring test, which is a simple exercise test designed to measure how well people with interstitial lung disease (ILD) can use their arms and hands. ILD is a group of serious lung conditions that cause breathing difficulties and can lead to more severe health issues. Researchers want to see if this test is a reliable way to evaluate upper body function in patients with ILD, as no studies have looked into this before.
To be eligible for the trial, participants need to be between 18 and 75 years old and have a confirmed diagnosis of ILD. They should not have had any recent lung infections or other serious health issues that could affect their ability to exercise. Those who join the study will perform the pegboard and ring test, and the information gathered will help improve understanding of exercise capacity in people with ILD. This could lead to better care and support for patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients diagnosed with ILD according to ATS/ERS criteria,
- • Ages between 18 and 75,
- • Pulmonary infection during the previous month,
- • Participants who voluntarily participated in the study were included.
- Exclusion Criteria:
- * Patients were excluded if they had:
- • Acute pulmonary exacerbation or respiratory infection in the last four weeks
- • Obstructive lung disease
- • Systemic conditions affecting neurological, neuromuscular, orthopedic, or physical functions
- • Recent participation in a planned exercise program (within three months)
- • Cognitive impairment affecting exercise test understanding
- • Contraindications to exercise testing per the American Sports Medicine Association
- • Cancer, renal, or hepatic disease
- • Aortic stenosis, complex arrhythmia, or aortic aneurysm
- • Serious cardiovascular diseases like uncontrolled hypertension, diabetes, heart failure, or arrhythmia
About Gazi University
Gazi University, a leading research institution based in Ankara, Turkey, is committed to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates cutting-edge research with clinical practice to explore new therapeutic approaches and enhance existing treatments. Gazi University adheres to the highest ethical standards and regulatory guidelines, ensuring the integrity and safety of its clinical trials. By fostering partnerships with healthcare professionals and academic institutions, Gazi University aims to contribute significantly to the global scientific community and address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Meral BOŞNAK GÜÇLÜ, Prof. Dr.
Study Director
Gazi University
Nazire Nur YILDIZ, M.Sc.
Study Chair
Nigde Omer Halisdemir University
Nilgün YILMAZ DEMİRCİ, Prof. Dr.
Principal Investigator
Gazi University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported